Dupilumab Treatment for Prurigo Nodularis and Pruritis
Authors Ross Tanis MD MS, Katalin Ferenczi MD, and B Michael Payette MD MBAB present a case where they demonstrated that treatment of Prurigo Nodularis (PN) with dupilumab significantly decreased pruritis and the size and number of new lesions after 2 months of treatment.
INTRODUCTION
Prurigo nodularis is an intensely pruritic skin disease in which dome-shaped papulonodules result from chroni …
Authors Ross Tanis MD MS, Katalin Ferenczi MD, and B Michael Payette MD MBAB present a case where they demonstrated that treatment of Prurigo Nodularis (PN) with dupilumab significantly decreased pruritis and the size and number of new lesions after 2 months of treatment.
INTRODUCTION
Prurigo nodularis is an intensely pruritic skin disease in which dome-shaped papulonodules result from chroni … Continue reading "Dupilumab Treatment for Prurigo Nodularis and Pruritis"
Here are the issue highlights for the JDD August issue with special focus on Psoriasis:
Authors discuss the epidemiological, clinical, and histologic features of melasma and postinflammatory hyperpigmentation and important considerations for both established and emerging treatments in Therapeutic Insights in Melasma and Hyperpigmentation Management (CE credit is available)
Descriptive char … 